205 related articles for article (PubMed ID: 11463952)
1. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
[TBL] [Abstract][Full Text] [Related]
2. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
[TBL] [Abstract][Full Text] [Related]
3. The hemoregulatory peptide pEEDCK may inhibit stem cell proliferation via hydropathic binding to antisense sequence motifs in interleukin-11 and other growth factors.
Paukovits JB; Rutter R; Ganglberger E; Karlic HI; Marian B; Paukovits WR
Mol Pharmacol; 1999 Oct; 56(4):665-74. PubMed ID: 10496948
[TBL] [Abstract][Full Text] [Related]
4. Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 alpha.
Wark G; Heyworth CM; Spooncer E; Czaplewski L; Francis JM; Dexter TM; Whetton AD
Oncogene; 1998 Mar; 16(10):1319-24. PubMed ID: 9546433
[TBL] [Abstract][Full Text] [Related]
5. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.
de Wynter EA; Durig J; Cross MA; Heyworth CM; Testa NG
Stem Cells; 1998; 16(5):349-56. PubMed ID: 9766815
[TBL] [Abstract][Full Text] [Related]
6. Stem cell stimulation in vitro by the dekapeptide (pEEDCK)2: a single-factor alternative for multifactor cocktails.
Paukovits JB; Paukovits WR
Leukemia; 1995 Oct; 9 Suppl 1():S48-52. PubMed ID: 7475313
[TBL] [Abstract][Full Text] [Related]
7. Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.
Paukovits WR; Paukovits JB; Moser MH; Konstantinov S; Schulte-Hermann R
Exp Hematol; 1998 Aug; 26(9):851-8. PubMed ID: 9694506
[TBL] [Abstract][Full Text] [Related]
8. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-inflammatory protein-1alpha receptor expression on normal and chronic myeloid leukemia CD34+ cells.
Nicholls SE; Lucas G; Graham GJ; Russell NH; Mottram R; Whetton AD; Buckle AM
J Immunol; 1999 May; 162(10):6191-9. PubMed ID: 10229864
[TBL] [Abstract][Full Text] [Related]
10. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children.
Corazza F; Hermans C; Ferster A; Fondu P; Demulder A; Sariban E
Pediatr Res; 2004 Jan; 55(1):152-8. PubMed ID: 14561785
[TBL] [Abstract][Full Text] [Related]
12. Hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys: a new synthetic derivative for avoiding dimerization and loss of inhibitory activity.
Paukovits WR; Hergl A; Schulte-Hermann R
Mol Pharmacol; 1990 Sep; 38(3):401-9. PubMed ID: 2402229
[TBL] [Abstract][Full Text] [Related]
13. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
Cashman JD; Eaves AC; Wolpe S; Eaves CJ
Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
[No Abstract] [Full Text] [Related]
14. In vivo and in vitro effects of cytokines and the hemoregulatory peptide dimer (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 on G alpha16-positive hematopoiesis.
Pfeilstöcker M; Karlic H; Paukovits J; Anzenberger G; Louda N; Salamon J; Mühlberger H; Strobl H; Pittermann E; Heinz R
Leukemia; 1999 Apr; 13(4):590-4. PubMed ID: 10214866
[TBL] [Abstract][Full Text] [Related]
15. MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: effects of progenitor isolation method and cell-cell contact.
Liesveld JL; Harbol AW; Belanger T; Rosell KE; Abboud CN
Blood Cells Mol Dis; 2000 Aug; 26(4):261-75. PubMed ID: 11042027
[TBL] [Abstract][Full Text] [Related]
16. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
Jackson JD; Yan Y; Ewel C; Talmadge JE
Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
[TBL] [Abstract][Full Text] [Related]
17. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures.
Cashman JD; Eaves CJ; Sarris AH; Eaves AC
Blood; 1998 Oct; 92(7):2338-44. PubMed ID: 9746772
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
Rizzo MT; Regazzi E; Garau D; Akard L; Dugan M; Boswell HS; Rizzoli V; Carlo-Stella C
Cancer Res; 1999 Oct; 59(19):5047-53. PubMed ID: 10519422
[TBL] [Abstract][Full Text] [Related]
19. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
[TBL] [Abstract][Full Text] [Related]
20. A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors.
Youn BS; Jang IK; Broxmeyer HE; Cooper S; Jenkins NA; Gilbert DJ; Copeland NG; Elick TA; Fraser MJ; Kwon BS
J Immunol; 1995 Sep; 155(5):2661-7. PubMed ID: 7650394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
